Biogen, Inc. (BIIB)
177.34
-6.44
(-3.50%)
USD |
NASDAQ |
Apr 02, 16:00
177.32
-0.02
(-0.01%)
Pre-Market: 20:00
Biogen EPS Diluted (Quarterly) : -0.3333 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Gilead Sciences, Inc. | 1.742 |
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| Apellis Pharmaceuticals, Inc. | -0.4654 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.90M |
| Revenue (Quarterly) | 2.181B |
| Total Expenses (Quarterly) | 2.230B |
| Enterprise Value | 28.87B |
| Gross Profit Margin (Quarterly) | 68.12% |
| Profit Margin (Quarterly) | -2.24% |
| Earnings Yield | 4.97% |
| Operating Earnings Yield | 9.30% |
| Normalized Earnings Yield | 6.575 |